Cargando…

P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL.

Detalles Bibliográficos
Autores principales:	Chiba, Shigeru, Wook Lee, Jong, Ho Jang, Jun, Yoon, Sung-Soo, Oshikawa, Gaku, Usuki, Kensuke, Mun, Yeung-Chul, Kawakita, Toshiro, Imada, Kazunori, Cheong, June-Won, Noshiro, Masayoshi, Matsuda, Akira, Ozawa, Keiya, Mitani, Kinuko, Kanda, Yoshinobu, Nakao, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430427/ http://dx.doi.org/10.1097/01.HS9.0000970012.99987.60

Ejemplares similares

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study
por: Jang, Jun Ho, et al.
Publicado: (2020)

P827: EFFICACY AND SAFETY OF ROMIPLOSTIM ADDED TO IMMUNOSUPPRESSIVE THERAPY AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL
por: Yamazaki, H., et al.
Publicado: (2022)

Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan
por: Imada, Kazunori, et al.
Publicado: (2020)

A Single-Centre Experience of First-Line Romiplostim and Immunosuppressive Therapy in Patients With Aplastic Anemia
por: Dhingra, Gaurav, et al.
Publicado: (2023)

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis
por: Matsuda, Kensuke, et al.
Publicado: (2018)

Scotch 777 6250 CPI
Publicado: (2017)

777 mathematical conversation starters
por: dePillis, John
Publicado: (2004)

Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution
por: Matsuda, Akira, et al.
Publicado: (2022)

Gingival enlargement due to Cyclosporine A therapy in aplastic anaemia
por: Sabnis, Girish R., et al.
Publicado: (2011)

Cyclosporine monotherapy for severe aplastic anemia: a developing country experience
por: Al-Ghazaly, Jameel, et al.
Publicado: (2005)

Effective treatment of aplastic anemia secondary to chemoradiotherapy using cyclosporine A
por: Ruan, Jing, et al.
Publicado: (2021)

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia
por: Gao, Xuan, et al.
Publicado: (2022)

Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
por: Wan, Ziqi, et al.
Publicado: (2023)

Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
por: Chandrakala, S., et al.
Publicado: (2022)

Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
por: Chandrakala, S., et al.
Publicado: (2023)

Immunomodulation Therapy for Severe Aplastic Anemia: —ALG Versus ALG Plus Cyclosporin A—
por: Park, Chong Won, et al.
Publicado: (1989)

Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis
por: Li, Hongmin, et al.
Publicado: (2022)

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
por: Soff, Gerald A., et al.
Publicado: (2019)

Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine
por: Zhang, Lele, et al.
Publicado: (2023)

Successful Treatment of Methimazole-Induced Severe Aplastic Anemia by Granulocyte Colony-Stimulating Factor, Methylprednisolone, and Cyclosporin
por: Honda, Munehiro
Publicado: (2011)

The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Quality by Design in Downstream Process Development of Romiplostim
por: Pouri, Saeedeh, et al.
Publicado: (2022)

Romiplostim use in pregnant women with immune thrombocytopenia
por: Bussel, James B., et al.
Publicado: (2022)

EFFECT OF INSOLATION ON ‘777 OIL’ USED FOR PSORIASIS IN SIDDHA SYSTEM OF MEDICINE
por: Alam, Muzaffer, et al.
Publicado: (1985)

PREPARATION OF “777 OIL” USED FOR PSORIASIS IN SIDDHA MEDICINE BY MODIFIED METHOD
por: Alam, Muzaffer, et al.
Publicado: (1988)

In vivo morphogenesis of a new porcine enteric coronavirus, CV 777
por: Ducatelle, R., et al.
Publicado: (1981)

A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers
por: Makarenko, Igor, et al.
Publicado: (2023)

PB1950: MASS CYTOMETRY ANALYSIS IDENTIFIES T CELL IMMUNE SIGNATURE FOR APLASTIC ANEMIA AND PREDICTS RESPONSE TO CYCLOSPORINE
por: Zhang, L., et al.
Publicado: (2022)

Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study
por: Yang, Wenrui, et al.
Publicado: (2023)

S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
por: Prabahran, Ashvind, et al.
Publicado: (2023)

P792: CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA
por: Chang, Lixian, et al.
Publicado: (2023)

An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia
por: Chang, Lixian, et al.
Publicado: (2023)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
por: Palandri, Francesca, et al.
Publicado: (2012)

Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
por: Jawa, Vibha, et al.
Publicado: (2010)

Romiplostim as a treatment for immune thrombocytopenia: a review
por: Chalmers, Sarah, et al.
Publicado: (2015)

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia
por: Perdomo, Jose
Publicado: (2016)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
por: Pecci, Alessandro, et al.
Publicado: (2017)

A Review of Romiplostim Mechanism of Action and Clinical Applicability
por: Bussel, James B, et al.
Publicado: (2021)

Auroral molecular-emission effects on the atomic oxygen line at 777.4 nm
por: Oyama, Shin-ichiro, et al.
Publicado: (2018)

Peer review of the pesticide risk assessment of the active substance fenpicoxamid (XDE‐777)
por: Arena, Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5hc75pebuhvs5a8e2ogb83grhc